Qin Sun

Chunhui Road
Luzhou, 646000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

µORScreen: a lightweight consensus modeling framework for µ-opioid receptor ligand prediction and virtual screening.

µORScreen: a lightweight consensus modeling framework for µ-opioid receptor ligand prediction and virtual screening.

Journal: RSC advances

Published: April 11, 2026

Natural Product-Inspired PROTACs for Leukemia Therapy: Hederagenin-Driven Targeted Degradation of SKP2.

Natural Product-Inspired PROTACs for Leukemia Therapy: Hederagenin-Driven Targeted Degradation of SKP2.

Journal: Journal of medicinal chemistry

Published: February 10, 2026

Current status and research trends of coptisine: a bibliometric analysis (1995 to 2025).

Current status and research trends of coptisine: a bibliometric analysis (1995 to 2025).

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 24, 2025

Design of RGD-functionalized GSH-responsive pegylated polymeric protacs for selective BRD4 degradation and EndMT-driven cardiac fibrosis inhibition.

Design of RGD-functionalized GSH-responsive pegylated polymeric protacs for selective BRD4 degradation and EndMT-driven cardiac fibrosis inhibition.

Journal: Journal of nanobiotechnology

Published: August 19, 2025

Betulinic acid as a novel AT1R inhibitor: attenuation of liver fibrosis via modulation of endothelial-mesenchymal transition in chronic hepatic injury.

Betulinic acid as a novel AT1R inhibitor: attenuation of liver fibrosis via modulation of endothelial-mesenchymal transition in chronic hepatic injury.

Journal: Journal of translational medicine

Published: July 17, 2025

Design of nano mume Fructus charcoal by reshaping inflammatory microenvironment as biofunctional wound nanomedicine.

Design of nano mume Fructus charcoal by reshaping inflammatory microenvironment as biofunctional wound nanomedicine.

Journal: Materials today. Bio

Published: March 19, 2025

Research progress on nanoplatforms based delivery of traditional Chinese medicine against multi-drug resistance in breast cancer.

Research progress on nanoplatforms based delivery of traditional Chinese medicine against multi-drug resistance in breast cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 17, 2025

Targeted Degradation of Bromodomain-Containing Protein 4 Enabled by Reactive Oxygen Species-Activatable NanoPROTACs as an Efficient Strategy to Reverse Liver Fibrosis in Chronic Liver Injury.

Targeted Degradation of Bromodomain-Containing Protein 4 Enabled by Reactive Oxygen Species-Activatable NanoPROTACs as an Efficient Strategy to Reverse Liver Fibrosis in Chronic Liver Injury.

Journal: Journal of medicinal chemistry

Published: March 06, 2025

Hydrogel-mediated mitochondrial reprogramming for inducing cell death: a novel approach to overcoming gemcitabine resistance in pancreatic ductal adenocarcinoma.

Hydrogel-mediated mitochondrial reprogramming for inducing cell death: a novel approach to overcoming gemcitabine resistance in pancreatic ductal adenocarcinoma.

Journal: Materials today. Bio

Published: February 27, 2025

A novel NIR-dependent IDO-inhibiting ethosomes treatment melanoma through PTT/PDT/immunotherapy synergy.

A novel NIR-dependent IDO-inhibiting ethosomes treatment melanoma through PTT/PDT/immunotherapy synergy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: December 26, 2024

Simultaneously induce apoptosis and inhibiting metastasis of Triple negative breast cancer Enabled by a highly potent NIR fluorescent inhibitor.

Simultaneously induce apoptosis and inhibiting metastasis of Triple negative breast cancer Enabled by a highly potent NIR fluorescent inhibitor.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: November 15, 2024

Clinical Characteristics and Treatment Outcomes of Pediatric Drug-Resistant Mycoplasma pneumoniae Pneumonia in the Post-COVID-19 Era.

Clinical Characteristics and Treatment Outcomes of Pediatric Drug-Resistant Mycoplasma pneumoniae Pneumonia in the Post-COVID-19 Era.

Journal: Infection and drug resistance

Published: November 14, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026